These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2859970)

  • 1. Effects of beta-adrenoceptor stimulation on rectosigmoid motility in man.
    Lyrenäs E; Abrahamsson H; Dotevall G
    Dig Dis Sci; 1985 Jun; 30(6):536-40. PubMed ID: 2859970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectosigmoid motility response to beta-adrenoceptor stimulation in patients with the irritable bowel syndrome.
    Lyrenäs E; Abrahamsson H; Dotevall G
    Scand J Gastroenterol; 1985 Dec; 20(10):1163-8. PubMed ID: 2869573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of beta-adrenergic stimulation to affect cholecystokinin-stimulated sigmoid motility in man.
    Lyrenäs E; Abrahamsson H; Dotevall G
    Scand J Gastroenterol; 1985 Dec; 20(10):1169-74. PubMed ID: 2869574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta adrenergic influence on esophageal and colonic motility in man.
    Lyrenäs E
    Scand J Gastroenterol Suppl; 1985; 116():1-48. PubMed ID: 2864739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of beta-adrenoceptor blocking drugs on human sigmoid colonic motility.
    Abrahamsson H; Lyrenäs E; Dotevall G
    Dig Dis Sci; 1983 Jul; 28(7):590-4. PubMed ID: 6134604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta adrenergic influence on oesophageal peristalsis in man.
    Lyrenäs E; Abrahamsson H
    Gut; 1986 Mar; 27(3):260-6. PubMed ID: 2870956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.
    Greefhorst AP; van Herwaarden CL
    Eur J Clin Pharmacol; 1983; 24(2):173-8. PubMed ID: 6132819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prenalterol in asthmatic patients.
    Löfdahl CG; Svedmyr N
    Eur J Clin Pharmacol; 1982 Oct; 23(4):297-302. PubMed ID: 6129142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the beta-adrenergic inhibition of motility in cat colon strips.
    Ek B; Lundgren B
    Eur J Pharmacol; 1982 Jan; 77(1):25-31. PubMed ID: 6120845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity.
    Ek BA; Bjellin LA; Lundgren BT
    Gastroenterology; 1986 Feb; 90(2):400-7. PubMed ID: 2867001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man.
    Rönn O; Fellenius E; Graffner C; Johnsson G; Lundborg P; Svensson L
    Eur J Clin Pharmacol; 1980 Feb; 17(2):81-6. PubMed ID: 6102914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on mechanisms for beta-adrenoceptor mediated inhibition of colon motility.
    Ek B
    Acta Physiol Scand Suppl; 1985; 546():1-39. PubMed ID: 2869641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
    Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
    Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A; Klein G; Bibra HV; Sauer E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen.
    Poller U; Fuchs B; Gorf A; Jakubetz J; Radke J; Pönicke K; Brodde OE
    Cardiovasc Res; 1998 Oct; 40(1):211-22. PubMed ID: 9876334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.
    Hedberg A; Carlsson E; Fellenius E; Lundgren B
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):185-91. PubMed ID: 6121296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
    Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
    Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
    [No Abstract]   [Full Text] [Related]  

  • 18. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA; Oltmanns D
    Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction in healthy volunteers between prenalterol, a selective beta 1-adrenoceptor agonist, and metoprolol or propranolol.
    Rönn O; Johnsson G; Lundborg P
    J Cardiovasc Pharmacol; 1981; 3(3):477-84. PubMed ID: 6168829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.